Close Menu

obesity

Research conducted under the five-year CRADA could lead to the development of a new blood test that predicts patients at risk for heart disease and metabolic syndrome. The collaboration could also lead to the development of new targeted drugs.

If the drug reaches the market, likely through a partnership with a pharma, UC Davis stands to receive a "modest" royalty based on sales of the drug as part of an exclusive licensing agreement it signed with Arete.

Shamil Sunyaev, an assistant professor of medicine at Harvard Medical School, has been studying how resequencing all human exons could help discover genes related to human traits. He spoke with In Sequence this week.

Georgia Biotech Tort-Shield Bill, Michigan 'Cluster of Innovation,' Maryland Nanobiotechnology Grants, North Carolina Biotechnology Center, Solano Economic Development Corp., Hong Kong Stimulus Package

Papers of Note for Jan 2009

Premium

Sequencing-Related Papers of Note, Published Jan. 2009

Though the budget would raise by one-third, or to $20 million, the state's maximum annual outlay to life-sci center grants covered by the Commonwealth Life Sciences Investment Program, it still falls short of the $25 million annual limit set by the Massachusetts Life Sciences Act.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.